CN105535344A - Traditional Chinese medicine composition for treating breast lobular hyperplasia caused by qi stagnation and blood stasis - Google Patents
Traditional Chinese medicine composition for treating breast lobular hyperplasia caused by qi stagnation and blood stasis Download PDFInfo
- Publication number
- CN105535344A CN105535344A CN201610000098.XA CN201610000098A CN105535344A CN 105535344 A CN105535344 A CN 105535344A CN 201610000098 A CN201610000098 A CN 201610000098A CN 105535344 A CN105535344 A CN 105535344A
- Authority
- CN
- China
- Prior art keywords
- radix
- blood stasis
- chinese medicine
- stagnation
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 43
- 239000008280 blood Substances 0.000 title claims abstract description 31
- 210000004369 blood Anatomy 0.000 title claims abstract description 31
- 239000000203 mixture Substances 0.000 title claims abstract description 19
- 210000000481 breast Anatomy 0.000 title abstract description 7
- 206010020718 hyperplasia Diseases 0.000 title abstract description 5
- 241000722823 Armadillidium Species 0.000 claims description 10
- 241001279228 Campylotropis hirtella Species 0.000 claims description 10
- 241001251068 Formica fusca Species 0.000 claims description 10
- 241000612122 Myrsine Species 0.000 claims description 10
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 10
- 241000180649 Panax notoginseng Species 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 15
- 229940126680 traditional chinese medicines Drugs 0.000 abstract 2
- 241000893563 Dysosma Species 0.000 abstract 1
- 244000248416 Fagopyrum cymosum Species 0.000 abstract 1
- 241000257303 Hymenoptera Species 0.000 abstract 1
- 241001506304 Kadsura japonica Species 0.000 abstract 1
- 244000047734 Paederia foetida Species 0.000 abstract 1
- 235000019116 Paederia foetida Nutrition 0.000 abstract 1
- 244000131316 Panax pseudoginseng Species 0.000 abstract 1
- 235000003181 Panax pseudoginseng Nutrition 0.000 abstract 1
- 241000908127 Porcellio scaber Species 0.000 abstract 1
- 208000002193 Pain Diseases 0.000 description 15
- 201000010099 disease Diseases 0.000 description 15
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 15
- 239000000796 flavoring agent Substances 0.000 description 9
- 235000019634 flavors Nutrition 0.000 description 9
- 230000008961 swelling Effects 0.000 description 8
- 231100000614 poison Toxicity 0.000 description 7
- 230000001737 promoting effect Effects 0.000 description 5
- 239000002994 raw material Substances 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 208000014674 injury Diseases 0.000 description 4
- 230000008736 traumatic injury Effects 0.000 description 4
- 208000006820 Arthralgia Diseases 0.000 description 3
- 206010007247 Carbuncle Diseases 0.000 description 3
- 208000019255 Menstrual disease Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 201000004792 malaria Diseases 0.000 description 3
- 230000002175 menstrual effect Effects 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- 201000004624 Dermatitis Diseases 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 206010017553 Furuncle Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010027514 Metrorrhagia Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- 206010053615 Thermal burn Diseases 0.000 description 2
- 208000019790 abdominal distention Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000003026 hypopharynx Anatomy 0.000 description 2
- 201000007227 lymph node tuberculosis Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003402 Arthropod sting Diseases 0.000 description 1
- 208000008035 Back Pain Diseases 0.000 description 1
- 206010007134 Candida infections Diseases 0.000 description 1
- 206010008531 Chills Diseases 0.000 description 1
- 240000007311 Commiphora myrrha Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010018045 Gastroptosis Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019345 Heat stroke Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006877 Insect Bites and Stings Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 206010028813 Nausea Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- 208000007027 Oral Candidiasis Diseases 0.000 description 1
- 206010034686 Peritonsillar abscess Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000006504 Scorpion Stings Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000004078 Snake Bites Diseases 0.000 description 1
- 206010041660 Splenomegaly Diseases 0.000 description 1
- 208000033809 Suppuration Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 241000287411 Turdidae Species 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 201000003984 candidiasis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 230000006735 deficit Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 208000003512 furunculosis Diseases 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 206010019847 hepatosplenomegaly Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000008693 nausea Effects 0.000 description 1
- 208000005346 nocturnal enuresis Diseases 0.000 description 1
- 230000003119 painkilling effect Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000002062 proliferating effect Effects 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/29—Berberidaceae (Barberry family), e.g. barberry, cohosh or mayapple
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/70—Polygonaceae (Buckwheat family), e.g. spineflower or dock
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
- A61K36/8905—Cyperus (flatsedge)
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention belongs to the technical field of traditional Chinese medicines, and aims at providing a traditional Chinese medicine composition according to the know mechanism of traditional Chinese medicines on breast lobular hyperplasia caused by qi stagnation and blood stasis and used for treating breast lobular hyperplasia caused by qi stagnation and blood stasis. The traditional Chinese medicine composition is prepared from, by mass, 3-10 g of pseudo-ginseng, 7.5-15 g of rhizoma cyperi, 10-20 g of dysosma, 0.75-1.5 g of Porcellio scaber Latreille, 3-3.5 g of black ants, 10-30 g of long-stalked kadsura, 15-25 g of paederia scandens, 15-32 g of fagopyrum dibotrys, 9-30 g of clovershrub and 3-10 g of radix bupleuri. The medicine is good in efficacy and quick in effect.
Description
Technical field
The present invention relates to technical field of Chinese medicine, be specifically related to a kind of Chinese medicine composition for the treatment of the cyclomastopathy of caused by energy stagnation and blood stasis, particularly for the field of the Chinese medicine composition of the cyclomastopathy patient of caused by energy stagnation and blood stasis.
Background technology
Cyclomastopathy is a kind of non-tumor the most common in disease of hyperplasia of mammary glands glands, the proliferative lesion of non-inflammation, all accounts for about 70% in cystic hyperplasia of breast, can betide the women at adolescence later any age.
Its symptom is: cyclomastopathy clinically main manifestations is: before menstrual onset 5 ~ 7 days, breast distension pain, and menstrual onset distending pain of the breast is alleviated, and even disappears, and occurs again periodically change before treating next menstrual onset.
So, with regard to how finding a kind of medicine effectively can treating the cyclomastopathy of above-mentioned caused by energy stagnation and blood stasis, be the problem that we will solve at present.
Summary of the invention
Along with the development of China's Chinese medicine, on the cyclomastopathy for the treatment of caused by energy stagnation and blood stasis, people appreciate the advantage of the above-mentioned disease of Chinese traditional treatment gradually, and the advantage such as the little and expense of toxic and side effects is low over the course for the treatment of, for the present situation of the cyclomastopathy of the above-mentioned caused by energy stagnation and blood stasis of existing western medical treatment, the object of the invention is to be to provide a kind of Chinese medicine composition for the treatment of the cyclomastopathy of caused by energy stagnation and blood stasis, to solve the cyclomastopathy patient restorative problem early of caused by energy stagnation and blood stasis.This medicine be with common Chinese medicine for raw material, there is instant effect, the feature such as evident in efficacy, and effectively can treat the cyclomastopathy of above-mentioned caused by energy stagnation and blood stasis.
For reaching the object of foregoing invention, the technical solution adopted in the present invention is: provide a kind of Chinese medicine composition for the treatment of the cyclomastopathy of caused by energy stagnation and blood stasis, it is characterized in that, each component of described medicine and mass parts thereof are than as follows:
Radix Notoginseng 3 ~ 10g, Rhizoma Cyperi 7.5 ~ 15g, Radix et Rhizoma Dysosmatis 10 ~ 20g, Armadillidium 0.75 ~ 1.5g, Formica fusca 3 ~ 3.5g, Caulis Kadsurae Longipedunculatae 10 ~ 30g, fevervine 15 ~ 25g, Rhizoma Fagopyri Dibotryis 15 ~ 32g, Radix Campylotropis Hirtella (Herba Myrsines Africanae) 9 ~ 30g, Radix Bupleuri 3 ~ 10g.
Treat a Chinese medicine composition for the cyclomastopathy of caused by energy stagnation and blood stasis, it is characterized in that, each component of described medicine and mass parts thereof are than as follows:
Radix Notoginseng 5 ~ 9g, Rhizoma Cyperi 8 ~ 13g, Radix et Rhizoma Dysosmatis 11 ~ 17g, Armadillidium 1 ~ 1.5g, Formica fusca 4 ~ 3.2g, Caulis Kadsurae Longipedunculatae 11 ~ 26g, fevervine 16 ~ 22g, Rhizoma Fagopyri Dibotryis 16 ~ 28g, Radix Campylotropis Hirtella (Herba Myrsines Africanae) 10 ~ 26g, Radix Bupleuri 5 ~ 9g.
Treat a Chinese medicine composition for the cyclomastopathy of caused by energy stagnation and blood stasis, it is characterized in that, each component of the Chinese medicine composition of described " preferred plan " and mass parts thereof are than as follows:
Radix Notoginseng 8g, Rhizoma Cyperi 12g, Radix et Rhizoma Dysosmatis 15g, Armadillidium 1.2g, Formica fusca 3g, Caulis Kadsurae Longipedunculatae 23g, fevervine 20g, Rhizoma Fagopyri Dibotryis 25g, Radix Campylotropis Hirtella (Herba Myrsines Africanae) 23g, Radix Bupleuri 8g.
Treat a Chinese medicine composition for the cyclomastopathy of caused by energy stagnation and blood stasis, it is characterized in that, described method comprises the steps to be prepared from:
A, above-mentioned raw materials Chinese medicine is picked decontamination and dust after, be ground into superfine end according to mass parts ratio stand-by;
B, traditionally prepare the method for Chinese kmedicine bolus, after being sieved by ground superfine myrrh thing, the medicine dedicated device putting into sterilizing room is mixed all, and (granularity of its watered pill is: 4.9mm-5.0mm), then dry, and bottled sealing is for subsequent use to be then prepared into the watered pill.
Treat a Chinese medicine composition for the cyclomastopathy of caused by energy stagnation and blood stasis, it is characterized in that, described instructions of taking is: taken for three times with every day by the watered pill prepared, morning, noon and afternoon service once, dosage 5.5g/ time, taking medicine before meal, take medicine 7-28 days, and disease obtains recovery from illness.
Each raw material Chinese medicine in prescription of the present invention is all documented in detail in Chinese Pharmacopoeia, Chinese dictionary and Chinese book on Chinese herbal medicine.The present invention selects wherein modal Chinese medicine to be raw material, gives full play to the pharmacological effect of each component:
Radix Notoginseng, nature and flavor: sweet, micro-hardship, temperature, have effect of dissipating blood stasis hemostasis, subduing swelling and relieving pain, are used for the treatment of spitting of blood, haematemesis, epistaxis, have blood in stool, the disease such as metrorrhagia, traumatic hemorrhage, breast abdomen twinge, tumbling and swelling;
Rhizoma Cyperi, nature and flavor: acrid in the mouth, be slightly cold, nontoxic, there is resolving depression of regulating the flow of vital energy, menstruction regulating and pain relieving, antiabortive effect, be used for the treatment of distending pain over the hypochondrium, mammary swelling is educated, hernia pain, menoxenia, gastral cavity abdomen feeling of fullness pain, belch acid regurgitation, vomiting and nausea, abdominal pain during menstruation, bleeding not during menses, the disease such as frequent fetal movement;
Radix et Rhizoma Dysosmatis, nature and flavor: bitter in the mouth, pungent, cool in nature, poisonous, having talks effect of eliminating stagnation, stasis-dispelling and pain-killing, heat-clearing and toxic substances removing, is used for the treatment of the diseases such as cough, laryngopharynx swelling and pain, scrofula, goiter, carbuncle, furuncle, venom, traumatic injury harm, arthromyodynia;
Armadillidium, nature and flavor: sour, warm, nontoxic, have effect of removing blood stasis, diuretic, removing toxic substances, pain relieving, are used for the treatment of diseases such as controlling chronic malaria malaria with splenomegaly, amenorrhea lump in the abdomen, urinary obstruction, infantile convulsion locked jaw, ability to speak pain, all skin ulcers of thrush;
Formica fusca, salty, flat, poisonous, control venom and furunculosis swells and ache;
Caulis Kadsurae Longipedunculatae, nature and flavor: sour, warm in nature, there is relaxing muscles and tendons to promote blood circulation, regulating QI to relieve pain, strengthening the spleen to promote digestion, effect of promoting the production of body fluid of astringing the lung, be used for the treatment of traumatic injury, fracture, impairment caused by overstrain, lumbago due to pathogenic wind-dampness, joint aches, food stagnation stagnation, stomachache, abdominal distention, chronic cough are breathed hard, few thirsty, the menoxenia in Tianjin, bed-wetting, the disease such as scald;
Fevervine, nature and flavor: sweet acid, flat, there is effect of expelling wind and removing dampness, promoting digestion and removing stagnation, removing toxic substances and promoting subsidence of swelling, promoting blood circulation and stopping pain, be used for the treatment of the diseases such as dispelling the wind and dampness pathogens arthralgia pain, dyspeptic abdominal distention, infantile malnutrition, diarrhoea, dysentery, heatstroke, jaundice, hepatitis, hepatosplenomegaly, cough, scrofula, acute appendicitis, innominate toxic swelling, foot damp-edema are rotten, burn and scald, eczema, dermatitis, traumatic injury, Serpentis flood dragon scorpion sting;
Rhizoma Fagopyri Dibotryis, nature and flavor: cool in nature, puckery, micro-pungent, there is heat-clearing and toxic substances removing, effect of eliminating carbuncle of invigorating blood circulation, expelling wind and removing dampness sore, snake bite and insect sting, be used for the treatment of the diseases such as lung abscess, lung-heat cough with asthma, laryngopharynx swelling and pain, dysentery, rheumatism arthromyodynia, traumatic injury, carbuncle cancer, heat-clearing and toxic substances removing, evacuation of pus blood stasis dispelling, measles pneumonia, peritonsillar abscess;
Radix Campylotropis Hirtella (Herba Myrsines Africanae), nature and flavor: bitter, micro-sweet, cool in nature, there is effect of wind-expelling pain-stopping, clearing away heat-damp and promoting diuresis, astringing to arrest bleeding, be used for the treatment of rheumatic arthralgia, have a toothache, have loose bowels, dysentery, metrorrhagia, have blood in stool, effect of pulmonary tuberculosis hemoptysis;
Radix Bupleuri, nature and flavor: bitter in the mouth, pungent, cold nature, having induces sweat brings down a fever, effect of dispersing the stagnated live-QI to relieve the stagnation of QI, elevate a turnable ladder yang-energy, is used for the treatment of the disease such as proctoptosis, uterine prolapse, gastroptosis of fever caused by exogenous pathogens, alternate attack of chill and fever, malaria, hypochondriac pain due to stagnation of liverQI mammary swelling, headache dizziness, menoxenia, collapse of QI.
Medicine of the present invention is differential diagnosis of diseases based on the cyclomastopathy of Chinese traditional treatment caused by energy stagnation and blood stasis and the dialectical principle combined, think from pharmacological action and mechanism of action: with regard to cyclomastopathy one disease of caused by energy stagnation and blood stasis, each raw material herbal medicine efficacy in medicine provided by the present invention is played altogether, has good therapeutic effect to above-mentioned disease.
Detailed description of the invention
The present invention is exactly treatment for the cyclomastopathy of above-mentioned caused by energy stagnation and blood stasis and a kind of Chinese medicine formula proposed, and the medicine effect adopting this formula to prepare is good, instant effect, is the Chinese prescription of a treating both the principal and secondary aspects of a disease, is particularly suitable for Clinical practice.Be described in further detail below in conjunction with the specific embodiment of the present invention:
Embodiment 1:
Treat a Chinese medicine composition for the cyclomastopathy of caused by energy stagnation and blood stasis, each component of described medicine and mass parts thereof are than as follows:
Radix Notoginseng 8g, Rhizoma Cyperi 12g, Radix et Rhizoma Dysosmatis 15g, Armadillidium 1.2g, Formica fusca 3g, Caulis Kadsurae Longipedunculatae 23g, fevervine 20g, Rhizoma Fagopyri Dibotryis 25g, Radix Campylotropis Hirtella (Herba Myrsines Africanae) 23g, Radix Bupleuri 8g.
Embodiment 2:
Treat a Chinese medicine composition for the cyclomastopathy of caused by energy stagnation and blood stasis, each component of described medicine and mass parts thereof are than as follows:
Radix Notoginseng 9g, Rhizoma Cyperi 13g, Radix et Rhizoma Dysosmatis 17g, Armadillidium 1.5g, Formica fusca 3.2g, Caulis Kadsurae Longipedunculatae 26g, fevervine 22g, Rhizoma Fagopyri Dibotryis 28g, Radix Campylotropis Hirtella (Herba Myrsines Africanae) 26g, Radix Bupleuri 9g.
Embodiment 3:
Treat a Chinese medicine composition for the cyclomastopathy of caused by energy stagnation and blood stasis, each component of described medicine and mass parts thereof are than as follows:
Radix Notoginseng 10g, Rhizoma Cyperi 15g, Radix et Rhizoma Dysosmatis 20g, Armadillidium 1.5g, Formica fusca 3.5g, Caulis Kadsurae Longipedunculatae 30g, fevervine 25g, Rhizoma Fagopyri Dibotryis 32g, Radix Campylotropis Hirtella (Herba Myrsines Africanae) 30g, Radix Bupleuri 10g.
Model case:
Through cyclomastopathy patient totally 150 examples of clinical conditions caused by energy stagnation and blood stasis, the age is more than 37 years old 84 routine, only has 66 examples to be less than 37 years old.146 examples of fully recovering in 150 routine patients, effective 4 examples, total effective rate reaches 100%.After treatment, sick announcement is fully recovered.
Claims (3)
1. treat a Chinese medicine composition for the cyclomastopathy of caused by energy stagnation and blood stasis, it is characterized in that, each component of described medicine and mass parts thereof are than as follows:
Radix Notoginseng 3 ~ 10g, Rhizoma Cyperi 7.5 ~ 15g, Radix et Rhizoma Dysosmatis 10 ~ 20g, Armadillidium 0.75 ~ 1.5g, Formica fusca 3 ~ 3.5g, Caulis Kadsurae Longipedunculatae 10 ~ 30g, fevervine 15 ~ 25g, Rhizoma Fagopyri Dibotryis 15 ~ 32g, Radix Campylotropis Hirtella (Herba Myrsines Africanae) 9 ~ 30g, Radix Bupleuri 3 ~ 10g.
2. the Chinese medicine composition of the cyclomastopathy for the treatment of caused by energy stagnation and blood stasis according to claim 1, is characterized in that, each component of described medicine and mass parts thereof are than as follows:
Radix Notoginseng 5 ~ 9g, Rhizoma Cyperi 8 ~ 13g, Radix et Rhizoma Dysosmatis 11 ~ 17g, Armadillidium 1 ~ 1.5g, Formica fusca 4 ~ 3.2g, Caulis Kadsurae Longipedunculatae 11 ~ 26g, fevervine 16 ~ 22g, Rhizoma Fagopyri Dibotryis 16 ~ 28g, Radix Campylotropis Hirtella (Herba Myrsines Africanae) 10 ~ 26g, Radix Bupleuri 5 ~ 9g.
3. according to the Chinese medicine composition of the cyclomastopathy of the treatment caused by energy stagnation and blood stasis described in claim 1 to 2, it is characterized in that, each component of described medicine and mass parts thereof are than as follows:
Radix Notoginseng 8g, Rhizoma Cyperi 12g, Radix et Rhizoma Dysosmatis 15g, Armadillidium 1.2g, Formica fusca 3g, Caulis Kadsurae Longipedunculatae 23g, fevervine 20g, Rhizoma Fagopyri Dibotryis 25g, Radix Campylotropis Hirtella (Herba Myrsines Africanae) 23g, Radix Bupleuri 8g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610000098.XA CN105535344A (en) | 2016-01-01 | 2016-01-01 | Traditional Chinese medicine composition for treating breast lobular hyperplasia caused by qi stagnation and blood stasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610000098.XA CN105535344A (en) | 2016-01-01 | 2016-01-01 | Traditional Chinese medicine composition for treating breast lobular hyperplasia caused by qi stagnation and blood stasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105535344A true CN105535344A (en) | 2016-05-04 |
Family
ID=55815255
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610000098.XA Pending CN105535344A (en) | 2016-01-01 | 2016-01-01 | Traditional Chinese medicine composition for treating breast lobular hyperplasia caused by qi stagnation and blood stasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105535344A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106166188A (en) * | 2016-08-30 | 2016-11-30 | 罗嘉辉 | A kind of Chinese medicine treating cyclomastopathy |
-
2016
- 2016-01-01 CN CN201610000098.XA patent/CN105535344A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106166188A (en) * | 2016-08-30 | 2016-11-30 | 罗嘉辉 | A kind of Chinese medicine treating cyclomastopathy |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104189871A (en) | Medicated wine for treating osteoproliferation | |
| CN103520461B (en) | Medicine for treating allergic rhinitis | |
| CN104352587A (en) | Ointment for treating rhinitis | |
| CN105687409A (en) | Stone needle mud moxibustion and method for preparing same | |
| CN105343645A (en) | External traditional Chinese medicine ointment for treating verruca plana | |
| CN104161823B (en) | A kind of Chinese medicine for the treatment of aseptic necrosis of femoral head | |
| CN106729225A (en) | A kind of active pain relieving emplastrum and preparation method thereof | |
| CN105709074A (en) | Medicine for treating rheumatic arthritis and hyperostosis and preparation method | |
| CN105535344A (en) | Traditional Chinese medicine composition for treating breast lobular hyperplasia caused by qi stagnation and blood stasis | |
| CN101954040A (en) | Externally-applied medicament for treating hyperosteogeny and preparation method thereof | |
| CN102784347B (en) | Traditional Chinese medicine for treating headache | |
| CN106177639A (en) | One treats psoriatic Chinese medicine composition and preparation method thereof | |
| CN105521047A (en) | Traditional Chinese medicinal composition for treating loin and leg pain and preparation method of traditional Chinese medicinal composition | |
| CN104147512A (en) | Traditional Chinese medicine composition for treating wet and cold type sciatica | |
| CN104288696B (en) | It is a kind of to treat Chinese medicine of hemorrhoid and preparation method thereof | |
| CN106266312A (en) | A kind of Chinese medicine for oral administration ball treating femur head necrosis and preparation method thereof | |
| CN106039257A (en) | Traditional Chinese medicine mud-moxibustion ointment and preparation method thereof | |
| CN105935378B (en) | A kind of strong drug composition for treating rheumatic arthritis | |
| CN105311612A (en) | Traditional Chinese medicine for treating myospasm | |
| CN105194637A (en) | Traditional Chinese medicine preparation for treating influenza and preparation method | |
| CN105079472A (en) | Traditional Chinese medicinal ointment used for repairing scar left by burn and scald | |
| CN104056139A (en) | Traditional Chinese medicine for treating psoriasis | |
| CN103816317A (en) | Traditional Chinese medicine composition for treating conjunctivitis | |
| CN102106954A (en) | Chinese medicine composition for treating frostbite | |
| CN108096338A (en) | A kind of Chinese medicine composition pill for treating gout and preparation method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20160504 |
|
| WD01 | Invention patent application deemed withdrawn after publication |